ArticleFrontiers in medicine2026
Endoscopic resection of esophageal adenoid cystic carcinoma with submucosal origin and long-term follow-up: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: A rare case of esophageal adenoid cystic carcinoma treated by endoscopic submucosal excavation combined with radiotherapy.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal adenoid cystic carcinoma (EACC) is an exceptionally rare malignancy where diagnosis by conventional endoscopy remains challenging due to its submucosal growth pattern. We present a case of a 47-years-old male with an esophageal submucosal lesion detected during routine examination. Endoscopic ultrasound (EUS) precisely localized the lesion to the submucosal layer, revealing a hypoechoic mass with a characteristic sieve-like appearance and intact muscularis propria. The tumor was completely resected using endoscopic submucosal excavation (ESE), with histopathology confirming EACC. During 5 years of regular follow-up, the patient maintained excellent condition with no evidence of recurrence or metastasis. This case highlights the critical role of EUS in diagnosing and staging early EACC and demonstrates that endoscopic resection can achieve long-term cure in carefully selected patients, offering a minimally invasive alternative to traditional esophagectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.